Checkpoint Inhibitor, Immune Clinical Trials
2 recruitingDrug
Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
SarcomaCancerSolid Tumor, Adult+3 more
EpicentRx, Inc.140 enrolled6 locationsNCT04673942
Recruiting
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Triple-Negative Breast CancerRenal Cell CarcinomaNon-Small-Cell Lung Carcinoma+1 more
VastBiome800 enrolled1 locationNCT05037825